Jump to main content
Jump to site search

Issue 10, 2020
Previous Article Next Article

Protein degradation through covalent inhibitor-based PROTACs

Author affiliations

Abstract

Tremendous advancements in proteolysis targeting chimera (PROTAC) technology have been made in recent years. However, whether a covalent inhibitor-based PROTAC can be developed remains controversial. Here, we successfully developed chimeric degraders based on covalent inhibitors to degrade BTK and BLK kinases, demonstrating that covalent inhibitor-based PROTACs are viable and useful tools.

Graphical abstract: Protein degradation through covalent inhibitor-based PROTACs

Back to tab navigation

Supplementary files

Article information


Submitted
21 Oct 2019
Accepted
27 Dec 2019
First published
10 Jan 2020

Chem. Commun., 2020,56, 1521-1524
Article type
Communication

Protein degradation through covalent inhibitor-based PROTACs

G. Xue, J. Chen, L. Liu, D. Zhou, Y. Zuo, T. Fu and Z. Pan, Chem. Commun., 2020, 56, 1521
DOI: 10.1039/C9CC08238G

Social activity

Search articles by author

Spotlight

Advertisements